Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2024 Earnings Conference Call March 18, 2025 10:00 AM ET
Company Participants
David Krempa – Chief Business Officer
Sean Brynjelsen – Chief Executive Officer
James Gruber – Chief Financial Officer
Ipek Trinkaus – Chief Commercial Officer
Conference Call Participants
Chase Knickerbocker – Craig-Hallum
Madison Elsaadi – B. Riley
Operator
Good day, and thank you for standing by. Welcome to the Eton Pharmaceuticals Investor Day and Fourth Quarter 2024 Earnings Results Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today’s conference is being recorded. After the speakers presentation there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference over to your speaker today, David Krempa, Chief Business Officer.
David Krempa
Hello, everyone, and welcome to Eton’s Fourth Quarter 2024 Results and 2025 Investor Day Conference Call. Before we begin the presentation, please take a look at our safe harbor statement. Our comments today may contain forward-looking statements and involve risks and uncertainties that could cause actual results to differ materially from those presented. Please see the forward-looking statements disclaimer in our earnings release and the risk factors in the company’s filings with the SEC.
With that, I will now turn the call over to Sean Brynjelsen, our CEO, to begin the presentation.
Sean Brynjelsen
Thank you, David, and thank you, everyone, for joining us today. It’s an exciting time for us to be hosting this call, and we have a lot of important items to discuss. We’ll begin by reviewing our transformational last six months, our corporate vision and our three pillar strategy for long-term growth. Then James will discuss our fourth quarter and full year 2024 financial results.
After that, we will provide a deep dive into the significant potential we see
